Variant report
Variant | nsv826752 |
---|---|
Chromosome Location | chr13:95974510-95976514 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147924890 | chr13:95974525-95974526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541792482 | chr13:95974554-95974555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs61974991 | chr13:95974576-95974577 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371505097 | chr13:95974587-95974588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574521328 | chr13:95974672-95974673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374900537 | chr13:95974722-95974723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368172298 | chr13:95974743-95974744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142111140 | chr13:95974757-95974758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144231051 | chr13:95974787-95974788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200038901 | chr13:95974789-95974790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2484980 | chr13:95974790-95974791 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs200602374 | chr13:95974791-95974792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201244594 | chr13:95974792-95974793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4773883 | chr13:95974793-95974794 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs569327094 | chr13:95974794-95974795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200527038 | chr13:95974795-95974796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531738407 | chr13:95974808-95974809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187970379 | chr13:95974815-95974816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548532957 | chr13:95974816-95974817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs202194235 | chr13:95974845-95974846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542962369 | chr13:95974862-95974863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568126757 | chr13:95974908-95974909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191881029 | chr13:95974912-95974913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112717538 | chr13:95974934-95974935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547687624 | chr13:95974978-95974979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570854570 | chr13:95975028-95975029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150378870 | chr13:95975057-95975058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556514488 | chr13:95975058-95975059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576066244 | chr13:95975074-95975075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9584295 | chr13:95975126-95975127 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs555369442 | chr13:95975140-95975141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572080537 | chr13:95975183-95975184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4773884 | chr13:95975185-95975186 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs145058183 | chr13:95975203-95975204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377608067 | chr13:95975280-95975281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71679571 | chr13:95975281-95975282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs398117773 | chr13:95975292-95975293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9524909 | chr13:95975293-95975294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35112150 | chr13:95975294-95975295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371697063 | chr13:95975295-95975296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs578030627 | chr13:95975318-95975319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141033588 | chr13:95975322-95975323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182980870 | chr13:95975334-95975335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377120783 | chr13:95975343-95975344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369474808 | chr13:95975347-95975348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563357030 | chr13:95975374-95975375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2992913 | chr13:95975382-95975383 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs75306461 | chr13:95975389-95975390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs548400663 | chr13:95975394-95975395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561698316 | chr13:95975409-95975410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:95971000-95976400 | Weak transcription | K562 | blood |
2 | chr13:95972600-95976200 | Weak transcription | HUVEC | blood vessel |
3 | chr13:95974400-95974600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr13:95974800-95976200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr13:95976200-95976400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr13:95976200-95977000 | Enhancers | HUVEC | blood vessel |
7 | chr13:95976200-95977200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr13:95976400-95976800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr13:95976400-95976800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr13:95976400-95976800 | Enhancers | K562 | blood |